SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950103-22-013822
Filing Date
2022-08-09
Accepted
2022-08-09 16:09:22
Documents
15
Period of Report
2022-08-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp178412_8k.htm   iXBRL 8-K 28912
2 EXHIBIT 1.1 dp178412_ex0101.htm EX-1.1 267320
3 EXHIBIT 5.1 dp178412_ex0501.htm EX-5.1 13595
4 GRAPHIC image_002.jpg GRAPHIC 2486
  Complete submission text file 0000950103-22-013822.txt   553959

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE pgen-20220809.xsd EX-101.SCH 2959
6 XBRL LABEL FILE pgen-20220809_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE pgen-20220809_pre.xml EX-101.PRE 22359
9 EXTRACTED XBRL INSTANCE DOCUMENT dp178412_8k_htm.xml XML 3475
Mailing Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876
Business Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876 301-556-9900
PRECIGEN, INC. (Filer) CIK: 0001356090 (see all company filings)

IRS No.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36042 | Film No.: 221148345
SIC: 2834 Pharmaceutical Preparations